Filed: 2/11/2025ACC: 0001622627-25-000008
📋 What this filing means
ROSALIND ADVISORS, INC. filed this quarterly 13F‑HR report disclosing 40 equity positions with a total reported market value of $195.58M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
40
Positions
$195.58M
Total AUM (reported)
37.96M
Total Shares
Allocation by class
COM NEW$86.84M44.4%
COM$77.79M39.8%
SHS NEW$11.18M5.7%
SPONSORED ADS$9.64M4.9%
PUT$8.69M4.4%
CALL$1.22M0.6%
CL A NEW$220.0K0.1%
Portfolio Concentration
Top 3$62.40M31.9%
4–10$66.21M33.9%
11–25$61.16M31.3%
Rest$5.80M3.0%
Top 3 weight
31.9%
Top 10 weight
65.8%
Voting Authority Distribution
Total shares with voting rights: 37.76M
Sole
Full voting authority
37.76M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole40
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings40
Rows:
DELCATH SYS INC
SOLEShares2.65M
TypeSH
Market value$31.91M
16.32%
Sole
2.65M
Shared
0.00
None
0.00
MYOMO INC
SOLEShares3M
TypeSH
Market value$19.31M
9.87%
Sole
3M
Shared
0.00
None
0.00
MEDIWOUND LTD
SOLEShares628.05K
TypeSH
Market value$11.18M
5.72%
Sole
628.05K
Shared
0.00
None
0.00
CHIMERIX INC
SOLEShares3.05M
TypeSH
Market value$10.61M
5.43%
Sole
3.05M
Shared
0.00
None
0.00
XERIS BIOPHARMA HOLDINGS INC
SOLEShares3.10M
TypeSH
Market value$10.53M
5.38%
Sole
3.10M
Shared
0.00
None
0.00
ABEONA THERAPEUTICS INC
SOLEShares1.81M
TypeSH
Market value$10.06M
5.14%
Sole
1.81M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares1.13M
TypeSH
Market value$9.64M
4.93%
Sole
1.13M
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares870K
TypeSH
Market value$9.27M
4.74%
Sole
870K
Shared
0.00
None
0.00
SAVARA INC
SOLEShares2.65M
TypeSH
Market value$8.15M
4.17%
Sole
2.65M
Shared
0.00
None
0.00
FENNEC PHARMACEUTICALS INC
SOLEShares1.26M
TypeSH
Market value$7.96M
4.07%
Sole
1.26M
Shared
0.00
None
0.00
CYBIN INC
SOLEShares810.92K
TypeSH
Market value$7.15M
3.66%
Sole
810.92K
Shared
0.00
None
0.00
VERONA PHARMA PLC
SOLEShares150K
TypeSH
Market value$6.97M
3.56%
Sole
150K
Shared
0.00
None
0.00
INSPIREMD INC
SOLEShares2.50M
TypeSH
Market value$6.56M
3.36%
Sole
2.50M
Shared
0.00
None
0.00
OPTINOSE INC
SOLEShares877K
TypeSH
Market value$5.86M
3.00%
Sole
876.99K
Shared
0.00
None
0.00
PROFOUND MED CORP
SOLEShares692.18K
TypeSH
Market value$5.20M
2.66%
Sole
692.18K
Shared
0.00
None
0.00
VERASTEM INC
SOLEShares900K
TypeSH
Market value$4.65M
2.38%
Sole
900K
Shared
0.00
None
0.00
TREVI THERAPEUTICS INC
SOLEShares1.06M
TypeSH
Market value$4.38M
2.24%
Sole
1.06M
Shared
0.00
None
0.00
CASSAVA SCIENCES INC
SOLEShares417.40K
TypeSH
Market value$3.65M
1.87%
Sole
417.40K
Shared
0.00
None
0.00
REPLIMUNE GROUP INC
SOLEShares260K
TypeSH
Market value$3.15M
1.61%
Sole
260K
Shared
0.00
None
0.00
POLYPID LTD
SOLEShares1.02M
TypeSH
Market value$3.11M
1.59%
Sole
1.02M
Shared
0.00
None
0.00
BIOMEA FUSION INC
SOLEShares910.70K
TypeSH
Market value$2.76M
1.41%
Sole
910.70K
Shared
0.00
None
0.00
COMPASS PATHWAYS PLC
SOLEShares707.63K
TypeSH
Market value$2.67M
1.37%
Sole
707.63K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares303.86K
TypeSH
Market value$2.57M
1.32%
Sole
303.86K
Shared
0.00
None
0.00
ALPHA COGNITION INC
SOLEShares252.75K
TypeSH
Market value$1.49M
0.76%
Sole
252.75K
Shared
0.00
None
0.00
CASSAVA SCIENCES INC
SOLEShares417.40K
TypeSH
Market value$985.1K
0.50%
Sole
417.40K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
DELCATH SYS INCSOLE | COM NEW | 2.65M | SH | $31.91M 16.32% | 2.65M | 0.00 | 0.00 |
MYOMO INCSOLE | COM NEW | 3M | SH | $19.31M 9.87% | 3M | 0.00 | 0.00 |
MEDIWOUND LTDSOLE | SHS NEW | 628.05K | SH | $11.18M 5.72% | 628.05K | 0.00 | 0.00 |
CHIMERIX INCSOLE | COM | 3.05M | SH | $10.61M 5.43% | 3.05M | 0.00 | 0.00 |
XERIS BIOPHARMA HOLDINGS INCSOLE | COM | 3.10M | SH | $10.53M 5.38% | 3.10M | 0.00 | 0.00 |
ABEONA THERAPEUTICS INCSOLE | COM NEW | 1.81M | SH | $10.06M 5.14% | 1.81M | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 1.13M | SH | $9.64M 4.93% | 1.13M | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 870K | SH | $9.27M 4.74% | 870K | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 2.65M | SH | $8.15M 4.17% | 2.65M | 0.00 | 0.00 |
FENNEC PHARMACEUTICALS INCSOLE | COM | 1.26M | SH | $7.96M 4.07% | 1.26M | 0.00 | 0.00 |
CYBIN INCSOLE | COM NEW | 810.92K | SH | $7.15M 3.66% | 810.92K | 0.00 | 0.00 |
VERONA PHARMA PLCSOLE | SPONSORED ADS | 150K | SH | $6.97M 3.56% | 150K | 0.00 | 0.00 |
INSPIREMD INCSOLE | COM | 2.50M | SH | $6.56M 3.36% | 2.50M | 0.00 | 0.00 |
OPTINOSE INCSOLE | COM NEW | 877K | SH | $5.86M 3.00% | 876.99K | 0.00 | 0.00 |
PROFOUND MED CORPSOLE | COM NEW | 692.18K | SH | $5.20M 2.66% | 692.18K | 0.00 | 0.00 |
VERASTEM INCSOLE | COM NEW | 900K | SH | $4.65M 2.38% | 900K | 0.00 | 0.00 |
TREVI THERAPEUTICS INCSOLE | COM | 1.06M | SH | $4.38M 2.24% | 1.06M | 0.00 | 0.00 |
CASSAVA SCIENCES INCSOLE | PUT | 417.40K | SH | $3.65M 1.87% | 417.40K | 0.00 | 0.00 |
REPLIMUNE GROUP INCSOLE | COM | 260K | SH | $3.15M 1.61% | 260K | 0.00 | 0.00 |
POLYPID LTDSOLE | COM | 1.02M | SH | $3.11M 1.59% | 1.02M | 0.00 | 0.00 |
BIOMEA FUSION INCSOLE | PUT | 910.70K | SH | $2.76M 1.41% | 910.70K | 0.00 | 0.00 |
COMPASS PATHWAYS PLCSOLE | SPONSORED ADS | 707.63K | SH | $2.67M 1.37% | 707.63K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 303.86K | SH | $2.57M 1.32% | 303.86K | 0.00 | 0.00 |
ALPHA COGNITION INCSOLE | COM NEW | 252.75K | SH | $1.49M 0.76% | 252.75K | 0.00 | 0.00 |
CASSAVA SCIENCES INCSOLE | COM | 417.40K | SH | $985.1K 0.50% | 417.40K | 0.00 | 0.00 |
Page 1 of 2